Sales rise 3.37% to Rs 81.93 crore
Net profit of Hester Biosciences declined 73.94% to Rs 1.29 crore in the quarter ended March 2025 as against Rs 4.95 crore during the previous quarter ended March 2024. Sales rose 3.37% to Rs 81.93 crore in the quarter ended March 2025 as against Rs 79.26 crore during the previous quarter ended March 2024.For the full year,net profit rose 45.53% to Rs 27.49 crore in the year ended March 2025 as against Rs 18.89 crore during the previous year ended March 2024. Sales rose 2.15% to Rs 311.10 crore in the year ended March 2025 as against Rs 304.55 crore during the previous year ended March 2024.
ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.Sales81.9379.26 3 311.10304.55 2 OPM %23.4120.09 -19.6317.62 - PBDT7.9213.61 -42 56.3749.13 15 PBT3.759.87 -62 39.5731.95 24 NP1.294.95 -74 27.4918.89 46
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
